(Q37449096)

20 August 2017

Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients (English)

1 reference

20 August 2017

0 references

0 references

1 reference

Kamyar Kalantar-Zadeh

object named as

Kamyar Kalantar-Zadeh

0 references

Matthew J Budoff

object named as

Matthew J Budoff

1 reference

20 August 2017

Ronney Shantouf

1 reference

20 August 2017

Naser Ahmadi

1 reference

20 August 2017

Jima Tiano

1 reference

20 August 2017

Ferdinand Flores

1 reference

20 August 2017

9 November 2007

1 reference

American Journal of Nephrology

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

275-279

1 reference

Impact of dyslipidemia in end-stage renal disease

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Inflammation in end-stage renal disease: sources, consequences, and therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Association between serum lipids and survival in hemodialysis patients and impact of race

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

C-reactive protein as an outcome predictor for maintenance hemodialysis patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C-reactive protein and in vivo oxidized LDL.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Inflammation and cardiovascular risk in dialysis patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Clinical epidemiology of cardiovascular disease in chronic renal disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Priapism caused by infection and an inflammatory process in the pelvic region

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000111061

Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000111061

Longitudinal Associations Between Dietary Protein Intake and Survival in Hemodialysis Patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2785908

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

3 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17992011

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17992011

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1159/000111061

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

17992011

1 reference